Skip to main content
OpenTrials
Completed

NCT Number: NCT00867646

Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine

Comparison Study of CoaguChek XS PT and Laboratory Innovin PT by NTUH Lab Medicine

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Taiwan University Hospital

Taipei, 100, Taiwan

About this study

This trial is going to proceed in two phases: Familiarization Phase and Evaluation Phase. The Preliminary Comparison Study consists of ten (10) patients being tested with the CoaguChek system and the laboratory reference method. This preliminary study is intended to help familiarize the operator with the dosing of the CoaguChek XS PT strips and to serve as an indicator as to whether some of the variables. Evaluation Phase consists of testing seventy (70) patient samples with the CoaguChek XS system and with the laboratory method.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Warfarin continuously treated patients

Exclusion criteria

  • Warfarin recently discontinuous treatment

Treatment and study plan

Primary outcomes

  1. Comparison of the PTINR measured by Coaguchek and laboratory CA1500

    Time frame: 2 Months

Sponsors and collaborators

Lead sponsor

National Taiwan University Hospital

Other

Registry information

Official study title

Comparison Study of CoaguChek XS Prothrombin Time and Laboratory Innovin PT by NTUH Lab Medicine

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Mar 24, 2009
Registry last updated
Dec 15, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.